TargED closes seed investment for the development of Microlyse – a next-generation thrombolytic clot-busting drug

Cincinnati, Ohio, US and Eindhoven, Netherlands – February 27, 2025 - Sirius Medical, the innovator of Surgical Marker...

 Eindhoven, the Netherlands – 4 February 2025 – As World Cancer Day is observed, Dutch medical device company Sirius...

TGD001 is being developed to offer patients with clotting disorders a faster, safer and more effective treatment than today’s...

Financing co-led by Johnson & Johnson Innovation – JJDC, Inc., Forbion and Novartis Venture Fund Lead first-in-class product...

Amsterdam, Netherlands – 13 August 2024 – Pitchbook has recently awarded Curie Capital with a 5th place among Dutch Venture...

   Learnings will be used in the clinical development programs of NET-targeting therapies such as Citryll’s lead...